The bidding window for the Taurian MPS SME IPO was open from September 9, 2025, to September 11, 2025. The basis of allotment will be finalised today, September 12, 2025. Here’s how you can check the IPO allotment status.
Taurian MPS IPO is a book-building issue of ₹42.53 crores, consisting entirely of a fresh issue of 0.25 crore equity shares. The price band is set at ₹162 to ₹171 per share. The tentative listing on NSE SME is September 16, 2025.
Gretex Corporate Services Ltd is the book-running lead manager, and Bigshare Services Pvt Ltd is the registrar for the issue.
The net proceeds from the fresh issue will be used towards:
(September 11, 2025, end of the day)
Category |
Subscription (times) |
Qualified Institutional Investors (QIBs) |
15.89 |
Non-Institutional Investors |
17.37 |
Individual Investors (IND category bidding for 2 Lots) |
6.86 |
Total |
11.69 |
As of 12 September 2025, Taurian MPS IPO GMP stood at ₹5. The estimated listing price is ₹176, i.e., a gain of 2.92% per share.
Source: Investorgain Report dated 12 September, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Taurian MPS is an engineering and manufacturing company that specializes in the design, manufacturing, and supply of advanced machinery such as crushing and screening plants, washing systems, and high-performance spare parts.
The company initially started its business via the supply of sand, aggregates, and spare parts and served sectors such as construction, mining, and aggregate processing. As the business evolved, Taurian MPS diversified its operations and expanded its portfolio to include a broad range of machinery and equipment.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here